Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Alabama for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Alabama only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Alabama (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Larry Brown (NPI 1124114863)

Field	Value
Entity Type	Individual
Organization	Larry Brown
Address	250 State Farm Pkwy
City	Birmingham
State	AL
ZIP	35209
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	October 4, 2006

Payer Source	Total Paid
Medicare	$1.4M
Medicaid	$0

Key Findings

This provider’s Medicare business is highly concentrated: Total Medicare revenue is $1.4M and the precomputed top 3 Medicare codes by revenue account for 80.8% of this provider's total Medicare revenue. In particular, J0178 (aflibercept) alone represents 67.0% of Medicare revenue with $931.3K reported, indicating a dominant revenue dependence on a single anti‑VEGF product.

Clinical/service-line profile is consistent with a retina-focused, injection‑centric practice: high-revenue codes are intravitreal pharmacologic agents (J0178, J2777) and related retinal procedures and imaging (67028, 92134, 92235). The presence of J7312 (dexamethasone intravitreal implant, $72.4K, 5.2%) and procedure code 67028 ($83.3K, 6.0%) shows a mix of sustained-release steroid implant use and frequent isolated intravitreal procedures alongside diagnostic imaging (92134, $41.7K, 3.0%).

The provider’s therapeutic mix favors aflibercept over alternatives: J0178 generates $931.3K (67.0% of Medicare revenue) and ranks #905 of 3204 providers nationally (72th percentile; typical, unremarkable volume for this code), while ranibizumab J2778 accounts for $13.6K (1.0%) and ranks #1170 of 1208 providers nationally (3th percentile; typical, unremarkable volume for this code). Faricimab J2777 contributes $109.5K (7.9%) with relatively large claim count but a mid/low national rank (#1427 of 2039, 30th percentile), and bevacizumab J9035 is $16.3K (1.2%) and ranks #465 of 1852 (75th percentile), indicating product selection concentrated toward aflibercept with variable use of alternatives.

Several specific codes show above‑typical national volume, signaling areas of competitive strength: J7312 ranks #32 of 492 providers nationally (93th percentile; notably above typical national volume for this code), 99214 ranks #25597 of 479517 providers nationally (95th percentile; notably above typical national volume for this code), and 92134 ranks #1477 of 26868 providers nationally (95th percentile; notably above typical national volume for this code). Conversely, J0178 is at a typical national volume (72th percentile) despite its large revenue share, suggesting the revenue concentration reflects product choice and pricing rather than an anomalously high injection volume relative to the full national peer set.

This provider is effectively single‑payer with respect to government programs: Total Medicare revenue is $1.4M while there is no Medicaid billing on file. The absence of Medicaid activity (no Medicaid billing on file) means there is no in‑state Medicaid footprint to evaluate for competitive positioning or payer diversification, which concentrates commercial and government exposure on Medicare beneficiaries and associated contracts.

Practice tenure supports a stable Medicare relationship: NPI enumerated (registered) on 2006-10-04 (~20 years ago), indicating long-standing participation in Medicare billing. That longevity, combined with high percentiles on E/M (99214) and retinal imaging (92134), suggests an established referral and follow‑up practice pattern.

Operationally, the mix of high-count injection codes and high-percentile imaging and E/M codes points to a high-frequency outpatient infusion/injection workflow with integrated diagnostic imaging: 67028 (947 claims, $83.3K, 6.0%) documents frequent isolated intravitreal injections as a discrete service, while 92134 (1.5K claims, $41.7K, 3.0%) and 99214 (708 claims, $65.1K, 4.7%) reflect substantial diagnostic and office follow-up volume to support that procedural throughput. By contrast, low-frequency surgical entries such as 67042 (12 claims, $10K, 0.7%) exist but do not drive material revenue, confirming an outpatient, clinic‑centric retina practice rather than an OR‑heavy surgical practice.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

15 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,390	$670	$931.3K
J2777	Injection, faricimab‑svoa, 0.1 mg	5,760	$20	$109.5K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	950	$90	$83.3K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	550	$130	$72.4K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	710	$90	$65.1K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,540	$30	$41.7K
92235	The provider uses a special dye, fluorescein that causes the blood vessels in the one or both eyes to stand out in photographic images taken with the use of multiframe timing, or serial images, taken…	190	$90	$17.7K
J9035	Injection, bevacizumab, 10 mg	300	$50	$16.3K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	150	$110	$16.3K
J2778	Injection, ranibizumab, 0.1 mg	130	$100	$13.6K

Showing 1–10 of 15

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 15 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Alabama Distribution

Larry Brown — 1 of 15 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Alabama

Full comparison — all codes billed, vs. state median

15 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	10	40	920	$690	$706.2K
J2777	16	20	7,140	$30	$267.9K
67028	23	40	990	$90	$82.5K
J2778	9	10	290	$180	$69.9K
J7312	2	10	280	$150	$63.3K
67042	21	20	20	$940	$24.6K
J9035	25	40	410	$50	$24.5K
99214	422	7,330	120	$80	$16.8K
92014	102	430	100	$80	$13.3K
92235	4	10	50	$90	$10.7K

Showing 1–10 of 15

Related Providers

Other providers that share a Tax Identification Number (TIN) with Larry Brown, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
John Bierly	TN	Ophthalmology Physician	$423.8K	$0
Brian Mulrooney	AL	Ophthalmology Physician	$274K	$0
Joseph Ceravolo	GA	Ophthalmology Physician	$150.2K	$0
Bret Fisher	AL	Ophthalmology Physician	$105.4K	$0
Brian Mahalak	AL	Optometrist	$99K	$0
Lawrence Debarge	AL	Ophthalmology Physician	$93K	$0
Stephen Solomon	AL	Neuro-ophthalmology Physician	$54.7K	$21.4K
Tracy Schroeder Swartz	AL	Optometrist	$74.3K	$0
Johnnie Nobles	AL	Optometrist	$39.4K	$0

Nearby Providers

Other providers in the same ZIP code as Larry Brown, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Core Diagnostic Laboratories LLC	AL	Clinical Medical Laboratory	$1.3M	$44.2M
Lab Works, LLC	AL	Clinical Medical Laboratory	$738.4K	$41.6M
Valentines Home Care, Inc.	AL	Durable Medical Equipment & Medical Supplies	$0	$13.6M
Devansh Lab Werks,inc	AL	Clinical Medical Laboratory	$1.9M	$5.9M
Grayson And Associates PC	AL	Psychiatry Physician	$0	$5M
Affinity Acquisitions, LLC	AL	Community Based Hospice Care Agency	$0	$4.8M
Metro Pediatrics PC	AL	Specialist	$0	$4.5M
Birmingham Radiological Group PC	AL	Diagnostic Radiology Physician	$0	$3.5M
Proteus Molecular And Clinical Lab LLC	AL	Clinical Medical Laboratory	$236.9K	$3.2M
Greg Eudy	AL	Rheumatology Physician	$3.3M	$0

Larry Brown — Billing Profile & Reimbursement Data

Sign up for Larry Brown — Billing Profile & Reimbursement Data policy alerts

Larry Brown — Billing Profile & Reimbursement Data

Sign up for Larry Brown — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References